CTS Dallas and Phoenix Labs successfully implemented WNV NAT testing on the Panther Testing Platform on Monday, June 17th. As previously communicated, the Grifols assay and sample requirements are the same, and the package insert has been modified to state the assay is specific to the Panther Testing Platform. The new package insert, assay history list, and platform history list are now available on our website.
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
CTS was recently notified that one of the tubes listed in the Sample Acceptability document...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
Just a reminder that the revised client forms implement today! Don't forget to toss your o...
CTS successfully implemented Donor-Screen HLA® Class I and II testing on the Stratec Biomedical ...